User profiles for Eugenia Quiros-Roldan
 | Maria Eugenia QUIROS ROLDANunibs Verified email at unibs.it Cited by 5341 |
[HTML][HTML] Compassionate use of remdesivir for patients with severe Covid-19
…, E Nicastri, R Oda, K Yo, E Quiros-Roldan… - … England Journal of …, 2020 - Mass Medical Soc
Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases,
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
…, L Imberti, A Sottini, S Paghera, E Quiros-Roldan… - Science, 2020 - science.org
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
…, L Imberti, A Sottini, S Paghera, E Quiros-Roldan… - Science, 2020 - science.org
INTRODUCTION Clinical outcomes of human severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…
[HTML][HTML] An immune-based biomarker signature is associated with mortality in COVID-19 patients
…, K Dobbs, L Imberti, A Sottini, E Quiros-Roldan… - JCI insight, 2021 - ncbi.nlm.nih.gov
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
contribute to disease severity of coronavirus disease 2019 (COVID-19). …
contribute to disease severity of coronavirus disease 2019 (COVID-19). …
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double …
F Raffi, H Jaeger, E Quiros-Roldan… - The Lancet infectious …, 2013 - thelancet.com
Background In the primary analysis of SPRING-2 at week 48, dolutegravir showed non-inferior
efficacy to and similar tolerability to raltegravir in adults infected with HIV-1 and naive for …
efficacy to and similar tolerability to raltegravir in adults infected with HIV-1 and naive for …
[HTML][HTML] Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy
…, M Tonoli, S Pasquali, F Viola, E Quiros-Roldan - Kidney International …, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus
disease (COVID-19), is a major pandemic challenging health care systems around the …
disease (COVID-19), is a major pandemic challenging health care systems around the …
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
…, G Verucchi, F Castelli, E Quiros Roldan… - The Journal of …, 2015 - academic.oup.com
Background Chronic cytomegalovirus (CMV) infection has been associated with immunosenescence
and immunoactivation in the general population. In human immunodeficiency virus …
and immunoactivation in the general population. In human immunodeficiency virus …
[PDF][PDF] Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
…, N Bansal, L Failla, A Sottini, E Quiros-Roldan… - Cell, 2021 - cell.com
COVID-19 exhibits extensive patient-to-patient heterogeneity. To link immune response
variation to disease severity and outcome over time, we longitudinally assessed circulating …
variation to disease severity and outcome over time, we longitudinally assessed circulating …
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
…, M Palmieri, S Ludovisi, F Castelli, E Quiros-Roldan… - elife, 2021 - elifesciences.org
Background: Recently, loss-of-function variants in TLR7 were identified in two families in
which COVID-19 segregates like an X-linked recessive disorder environmentally conditioned …
which COVID-19 segregates like an X-linked recessive disorder environmentally conditioned …
[HTML][HTML] Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
…, S Barrio, L Imberti, A Sottini, E Quiros-Roldan… - MedRxiv, 2020 - ncbi.nlm.nih.gov
T cells are involved in the early identification and clearance of viral infections and also
support the development of antibodies by B cells. This central role for T cells makes them a …
support the development of antibodies by B cells. This central role for T cells makes them a …